Medicare to negotiate lower prices for Botox and 14 other major drugs

Fifteen prescription medications, including Botox and the diabetes drug Trulicity, will be the focus of federal price negotiations that could lower prices for Medicare patients.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup